Table 4 VDR expression in different immunophenotypes of canine mammary carcinomas (CMCs) according to their histological subtypes
From: Vitamin D receptor (VDR) expression in different molecular subtypes of canine mammary carcinoma
| Histological subtype (No.) | VDR expression (No.;%) | No. of Luminal A cases (%) | No. of Luminal B cases (%) | No. of HER2 + cases (%) | No. of triple-negative cases (%) | P value |
|---|---|---|---|---|---|---|
| Simple | Positive (5;23.8) | 1 (14.3) | 0 | 0 | 4 (50.0) | |
| (n = 21) | Negative (16;76.2) | 6 (85.4) | 1 (100) | 5 (100) | 4 (50.0) | ns |
| Complex | Positive (8;29.6) | 3 (23.1) | 1 (25) | 0 | 4 (44.4) | |
| (n = 27) | Negative (19;70.4) | 10 (76.9) | 3 (75) | 1 (100) | 5 (55.6) | ns |
| Mixed | Positive (3;30) | 0 | 2 (33.3) | 0 | 1 (33.3) | |
| (n = 10) | Negative (7;70) | 1 (100) | 4 (66.7) | 0 | 2 (66.7) | ns |